Author response for 'The use of liraglutide 3.0 mg daily in the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first episode psychosis: results of a pilot randomised double-blind placebo-controlled trial'
| Autor: | null Whicher, Clare A, null Price, Hermione C, null Phiri, Peter, null Rathod, Shanaya, null Barnard-Kelly, Katharine, null Ngianga, Kandala, null Thorne, Kerensa, null Asher, Carolyn, null Peveler, Robert C, null McCarthy, Joanne, null Holt, Richard Ig |
|---|---|
| Rok vydání: | 2021 |
| DOI: | 10.1111/dom.14334/v3/response1 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|